CoChat

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)

Open access
Cohan, Pejman, East, Honey E, Galati, Sandi-Jo, Mercado, Jennifer U, Lim, Precious J, Lamerson, Michele, Smith, James J, Peters, Anne L, Yuen, Kevin C J · 2019 · The Journal of Clinical Endocrinology & Metabolism
Cited by 39

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Context: Primary bilateral macronodular adrenal hyperplasia (BMAH) is a rare form of adrenal Cushing syndrome conventionally treated with adrenalectomy. Medical treatment is often reserved for patients not eligible for surgery. However, to date there have been few studies about the efficacy of mifepristone for the treatment of BMAH associated with hypercortisolism. Objective: To describe a series of patients with hypercortisolism due to BMAH treated with mifepristone from multiple medical practices. Design: We retrospectively assessed four patients treated with mifepristone for hypercortisolism due to BMAH who had either failed unilateral adrenalectomy, declined surgery, or were poor surgical candidates. Results: Mifepristone induced clinical improvement and remission of the signs and symptoms of hypercortisolism in all described patients with BMAH. The median treatment duration at the time of efficacy response assessment was 5 months (range: 3 to 18 months). Improvement in cardiometabolic parameters was observed as early as 2 weeks after treatment was started. All patients achieved improvements in glycemic control and hypertension and had significant weight loss. The most common adverse event observed with mifepristone therapy was fatigue. Increases in TSH level occurred in two patients. Conclusion: Mifepristone can be an effective medical alternative to surgery in patients with hypercortisolism due to BMAH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-02638

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 39

Metadata

Authors
Cohan, P., East, H. E., Galati, S.-J., Mercado, J. U., Lim, P. J., Lamerson, M., Smith, J. J., Peters, A. L., & Yuen, K. C. J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-05-21
Volume
104
Issue
12
Pages
6279-6290
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2945677948
Cited by
39
References
14
FWCI
4.11
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH). https://app.cochat.ai/papers/10.1210/jc.2018-02638
The paper
Cohan, P., East, H. E., Galati, S.-J., Mercado, J. U., Lim, P. J., Lamerson, M., Smith, J. J., Peters, A. L., & Yuen, K. C. J. (2019). Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH). The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-02638

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.